Pfizer Advances Early-Stage Heart Failure Candidate With Completion of Chinese Phase 1 Study

Pfizer’s New Phase 1 Cancer Trial Adds Quiet Optionality to PFE’s Pipeline

Pfizer Ends Early-Stage Cancer Trial, Trimming Its Oncology Pipeline

Pfizer Advances Early-Stage Obesity Asset With New Gastric Emptying Study

Torray Investment Partners LLC Boosts Stake in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Mystic Asset Management Inc.

Pfizer Inc. to Issue Quarterly Dividend of $0.43 (NYSE:PFE)

PFE (Pfizer Inc.) posts 14.3 percent Q4 2025 EPS beat, stock rises 1.25 percent in regular trading. - Community Exit Signals

Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of "Hold" from Brokerages

PFE (Pfizer Inc.) registra un BPA del 14,3 por ciento en el cuarto trimestre de 2025, las acciones suben un 1,25 por ciento en las operaciones regulares. - Señales de…

Pfizer marks 350 straight quarterly dividends with $0.43 payout

Pfizer Inc. Declares Second-Quarter Cash Dividend on Common Stock for 2026, Payable June 12, 2026

Pfizer Inc. $PFE Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Pfizer Could Surprise Again This Earnings Season (Preview) (NYSE:PFE)

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Lyme Disease Vaccine Shows Over 70 Percent Efficacy

Pfizer GLP-1 weight loss drug available for pre-order in China